124 related articles for article (PubMed ID: 36623170)
41. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
[TBL] [Abstract][Full Text] [Related]
42. Serrated Epithelial Change Is Associated With High Rates of Neoplasia in Ulcerative Colitis Patients: A Case-controlled Study and Systematic Review With Meta-analysis.
Parian AM; Limketkai BN; Chowdhury R; Brewer GG; Salem G; Falloon K; Selaru F; Melia J; Lazarev MG
Inflamm Bowel Dis; 2021 Aug; 27(9):1475-1481. PubMed ID: 33295614
[TBL] [Abstract][Full Text] [Related]
43. Age at diagnosis of inflammatory bowel disease influences early development of colorectal cancer in inflammatory bowel disease patients: a nationwide, long-term survey.
Baars JE; Kuipers EJ; van Haastert M; Nicolaï JJ; Poen AC; van der Woude CJ
J Gastroenterol; 2012 Dec; 47(12):1308-22. PubMed ID: 22627504
[TBL] [Abstract][Full Text] [Related]
44. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.
Gong W; Lv N; Wang B; Chen Y; Huang Y; Pan W; Jiang B
Dig Dis Sci; 2012 Feb; 57(2):503-7. PubMed ID: 21938485
[TBL] [Abstract][Full Text] [Related]
45. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
Lindberg J; Stenling R; Palmqvist R; Rutegård J
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
[TBL] [Abstract][Full Text] [Related]
46. Systematic review with meta-analysis: the declining risk of colorectal cancer in ulcerative colitis.
Castaño-Milla C; Chaparro M; Gisbert JP
Aliment Pharmacol Ther; 2014 Apr; 39(7):645-59. PubMed ID: 24612141
[TBL] [Abstract][Full Text] [Related]
47. [Analysis on clinical features of patients with ulcerative colitis associated colorectal cancer].
Zhang HM; Han W; Yang H; Wang L; Bai XY; Ruan GC; Wu MX; Chen XF; Guo MY; Zhou RN; Zhou QY; Qian JM
Zhonghua Yi Xue Za Zhi; 2020 Mar; 100(8):599-603. PubMed ID: 32164114
[No Abstract] [Full Text] [Related]
48. Survival after colorectal cancer in patients with ulcerative colitis: a nationwide population-based Danish study.
Jensen AB; Larsen M; Gislum M; Skriver MV; Jepsen P; Nørgaard B; Sørensen HT
Am J Gastroenterol; 2006 Jun; 101(6):1283-7. PubMed ID: 16771950
[TBL] [Abstract][Full Text] [Related]
49. Thiopurine Therapy Reduces the Incidence of Colorectal Neoplasia in Patients with Ulcerative Colitis. Data from the ENEIDA Registry.
Gordillo J; Cabré E; Garcia-Planella E; Ricart E; Ber-Nieto Y; Márquez L; Rodríguez-Moranta F; Ponferrada Á; Vera I; Gisbert JP; Barrio J; Esteve M; Merino O; Muñoz F; Domènech E;
J Crohns Colitis; 2015 Dec; 9(12):1063-70. PubMed ID: 26351379
[TBL] [Abstract][Full Text] [Related]
50. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
Li Y; de Haar C; Chen M; Deuring J; Gerrits MM; Smits R; Xia B; Kuipers EJ; van der Woude CJ
Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
[TBL] [Abstract][Full Text] [Related]
51. Gross versus microscopic pancolitis and the occurrence of neoplasia in ulcerative colitis.
Mathy C; Schneider K; Chen YY; Varma M; Terdiman JP; Mahadevan U
Inflamm Bowel Dis; 2003 Nov; 9(6):351-5. PubMed ID: 14671483
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for the postoperative recurrence of ulcerative colitis-associated colorectal cancer.
Horio Y; Uchino M; Igeta M; Nagano K; Kusunoki K; Kuwahara R; Kimura K; Kataoka K; Beppu N; Ikeda M; Ikeuchi H
Int J Colorectal Dis; 2023 May; 38(1):113. PubMed ID: 37138034
[TBL] [Abstract][Full Text] [Related]
53. Colorectal cancer risk and mortality in patients with ulcerative colitis.
Langholz E; Munkholm P; Davidsen M; Binder V
Gastroenterology; 1992 Nov; 103(5):1444-51. PubMed ID: 1358741
[TBL] [Abstract][Full Text] [Related]
54. Relationship between ulcerative colitis patients treated with leukocytapheresis and ulcerative colitis-associated colorectal cancer.
Kinugasa T; Akagi Y; Murotani K; Romeo K; Yoshida T; Ryu Y; Shiratuchi I; Shirouzu K
Anticancer Res; 2011 Jul; 31(7):2547-52. PubMed ID: 21873173
[TBL] [Abstract][Full Text] [Related]
55. Motion - colonoscopic surveillance is more cost effective than colectomy in patients with ulcerative colitis: Arguments for the motion.
Lashner BA
Can J Gastroenterol; 2003 Feb; 17(2):119-21. PubMed ID: 12605250
[TBL] [Abstract][Full Text] [Related]
56. Colectomy is a risk factor for venous thromboembolism in ulcerative colitis.
Kaplan GG; Lim A; Seow CH; Moran GW; Ghosh S; Leung Y; Debruyn J; Nguyen GC; Hubbard J; Panaccione R
World J Gastroenterol; 2015 Jan; 21(4):1251-60. PubMed ID: 25632199
[TBL] [Abstract][Full Text] [Related]
57. Immunohistochemical expression of P53 and oncogenes in ulcerative colitis-associated colorectal carcinoma.
Brüwer M; Schmid KW; Senninger N; Schürmann G
World J Surg; 2002 Mar; 26(3):390-6. PubMed ID: 11865380
[TBL] [Abstract][Full Text] [Related]
58. Ulcerative colitis-associated colorectal cancer.
Yashiro M
World J Gastroenterol; 2014 Nov; 20(44):16389-97. PubMed ID: 25469007
[TBL] [Abstract][Full Text] [Related]
59. Frequency of Surveillance and Impact of Surveillance Colonoscopies in Patients With Ulcerative Colitis Who Developed Colorectal Cancer.
Cole EB; Shah Y; McLean LP; Yang YX; Khan N
Clin Colorectal Cancer; 2018 Jun; 17(2):e289-e292. PubMed ID: 29398423
[TBL] [Abstract][Full Text] [Related]
60. Methylated eyes absent 4 (EYA4) gene promotor in non-neoplastic mucosa of ulcerative colitis patients with colorectal cancer: evidence for a field effect.
Kisiel JB; Garrity-Park MM; Taylor WR; Smyrk TC; Ahlquist DA
Inflamm Bowel Dis; 2013 Sep; 19(10):2079-83. PubMed ID: 23867875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
